Your email has been successfully added to our mailing list.

×
0.000363517561579385 -2.76089287276496E-05 -0.000585539363430281 0.00054067485424783 -0.00147707768692411 -0.00187970789753418 -0.00280000552178584 -0.00280000552178584
Stock impact report

This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025? [Yahoo! Finance]

AbbVie Inc. (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
Company Research Source: Yahoo! Finance
Meta-Description: Drugmaker AbbVie could be set up for a big year in 2025 after completing another successful clinical trial for its Parkinson's medication. Biotech firms live and die on the success of the medications they develop and clinical testing is an essential part of that process. A failed test could portend a down period with reduced earnings, whereas a successful test could set the company's stock up for a major boost. Illinois-based AbbVie (NYSE: ABBV ) hopes its recent successful clinical test of a Parkinson's medication might make 2025 another banner year for the drugmaker. Don't Miss: Commercial real estate has historically outperformed the stock market, and this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today! If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it The company recently announce Show less Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ABBV alerts
Opt-in for
ABBV alerts

from News Quantified
Opt-in for
ABBV alerts

from News Quantified